| Product NDC: | 52125-414 |
| Proprietary Name: | Novolin70/30 |
| Non Proprietary Name: | Human Insulin |
| Active Ingredient(s): | 100 [USP'U]/mL & nbsp; Human Insulin |
| Administration Route(s): | SUBCUTANEOUS |
| Dosage Form(s): | INJECTION, SUSPENSION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 52125-414 |
| Labeler Name: | REMEDYREPACK INC. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA019991 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20130613 |
| Package NDC: | 52125-414-01 |
| Package Description: | 10 mL in 1 VIAL (52125-414-01) |
| NDC Code | 52125-414-01 |
| Proprietary Name | Novolin70/30 |
| Package Description | 10 mL in 1 VIAL (52125-414-01) |
| Product NDC | 52125-414 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Human Insulin |
| Dosage Form Name | INJECTION, SUSPENSION |
| Route Name | SUBCUTANEOUS |
| Start Marketing Date | 20130613 |
| Marketing Category Name | NDA |
| Labeler Name | REMEDYREPACK INC. |
| Substance Name | INSULIN HUMAN |
| Strength Number | 100 |
| Strength Unit | [USP'U]/mL |
| Pharmaceutical Classes | Insulin [Chemical/Ingredient],Insulin [EPC] |